Emergent Biosolutions, Inc. Competitors

EBS 
$22.03
*  
0.03
0.14%
Get EBS Alerts
*Delayed - data as of Aug. 1, 2014  -  Find a broker to begin trading EBS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

Emergent Biosolutions, Inc.
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Abbott Laboratories
ABT: NYSE
$ 42.03 -0.09 ▼ 3,897,391 $ 42.36
$ 41.814
$ 43.27
$ 32.70
27.65 63,126,496,170
AbbVie Inc.
ABBV: NYSE
$ 52.48 0.14 ▲ 11,582,292 $ 52.64
$ 51.75
$ 58.27
$ 42.25
20.26 83,446,663,680
ACADIA Pharmaceuticals Inc.
ACAD: NASDAQ-GS
$ 20.62 0.35 ▲ 1,053,782 $ 20.82
$ 19.80
$ 32
$ 15.64
NE 2,040,885,120
Acasti Pharma, Inc.
ACST: NASDAQ-CM
$ .93 -0.07 ▼ 448,613 $ 1
$ .91
$ 4.11
$ .80
NE 98,451,660
AcelRx Pharmaceuticals, Inc.
ACRX: NASDAQ-GM
$ 6.89 -0.07 ▼ 950,036 $ 7.15
$ 6.75
$ 13.64
$ 6.04
NE 298,447,240
Achaogen, Inc.
AKAO: NASDAQ-GM
$ 10.34 -0.47 ▼ 130,488 $ 11.06
$ 9.87
$ 19.69
$ 10.55
NE 182,821,540
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 7.04 0.19 ▲ 4,480,757 $ 7.34
$ 6.80
$ 8.61
$ 2.26
NE 681,443,840
Actavis, Inc.
ACT: NYSE
$ 216.89 2.63 ▲ 9,079,315 $ 217.99
$ 213.41
$ 230.77
$ 136.52
NE 37,835,809,830
Acura Pharmaceuticals, Inc.
ACUR: NASDAQ-CM
$ 1.03 -0.01 ▼ 44,946 $ 1.04
$ 1.01
$ 2.23
$ .98
NE 50,313,440
Adamas Pharmaceuticals, Inc.
ADMS: NASDAQ-GM
$ 16.09 0.18 ▲ 30,891 $ 16.42
$ 15.5401
$ 21.6299
$ 12.02
NE 268,831,720
Adamis Pharmaceuticals Corporation
ADMP: NASDAQ-CM
$ 3.64 -0.13 ▼ 54,655 $ 3.8206
$ 3.59
$ 7.25
$ 3.50
NE 38,227,280
Advaxis, Inc.
ADXS: NASDAQ-CM
$ 2.81 -0.03 ▼ 67,091 $ 2.88
$ 2.75
$ 11.70
$ 2.46
NE 54,157,130
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 1.0399 0.06 ▲ 100 $ 1.0399
$ 1.0399
$ 2.63
$ .75
NE 4,305,186
Aegerion Pharmaceuticals, Inc.
AEGR: NASDAQ-GS
$ 33.22 -0.39 ▼ 932,186 $ 34.48
$ 32.25
$ 101
$ 26.25
NE 979,425,260
AEterna Zentaris Inc.
AEZS: NASDAQ-CM
$ 1.14 -0.04 ▼ 871,553 $ 1.19
$ 1.13
$ 1.75
$ .99
5.7 64,425,960
Agile Therapeutics, Inc.
AGRX: NASDAQ-GM
$ 6 -0.25 ▼ 47,800 $ 6.3499
$ 5.97
$ 12.55
$ 5.05
NE 111,552,000
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 38.92 -1.38 ▼ 283,535 $ 40.36
$ 38.21
$ 50.37
$ 15.77
NE 1,321,567,520
Akebia Therapeutics, Inc.
AKBA: NASDAQ-GM
$ 21.44 -0.70 ▼ 79,086 $ 22.3136
$ 21.065
$ 31
$ 16.41
NE 434,417,280
Akorn, Inc.
AKRX: NASDAQ-GS
$ 34 0.07 ▲ 813,114 $ 34.65
$ 33.41
$ 37.079
$ 14.11
77.27 3,533,348,000
Alcobra Ltd.
ADHD: NASDAQ-GM
$ 17.32 -0.10 ▼ 75,116 $ 18.015
$ 17.0201
$ 26.96
$ 11
NE 236,192,840
Alder BioPharmaceuticals, Inc.
ALDR: NASDAQ-GM
$ 15.79 -1.10 ▼ 82,773 $ 16.98
$ 15.75
$ 22.95
$ 9.50
NE 486,395,160
Aldeyra Therapeutics, Inc.
ALDX: NASDAQ-CM
$ 3.50 -0.07 ▼ 6,354 $ 3.58
$ 3.11
$ 8.2223
$ 3.28
NE 19,477,500
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 159.12 0.13 ▲ 1,159,356 $ 161.11
$ 156.21
$ 185.43
$ 100.89
79.96 31,473,299,520
Alexza Pharmaceuticals, Inc.
ALXA: NASDAQ-GM
$ 4.79 -0.04 ▼ 109,018 $ 4.86
$ 4.65
$ 5.93
$ 3.92
NE 82,962,800
Alimera Sciences, Inc.
ALIM: NASDAQ-GM
$ 5.37 -0.41 ▼ 202,820 $ 5.8257
$ 5.23
$ 8.44
$ 1.65
NE 216,550,620